Penn Medicine's Dr. Robert Vonderheide, Director of the Abramson Cancer Center, discusses the FDA-approved cancer therapies developed at Penn Medicine that are now available to patients worldwide.
Twitter @PennMDForum
Related Presenters
Medical Oncology
Dr. Vonderheide is an internationally renowned cancer immunotherapy and translational research expert. Through a focus on novel immunotherapies for pancreatic cancer, melanoma and breast cancers, Dr. Vonderheide has mapped new models for ...
Related Videos
